Turn this list into pipeline.
Pharmaceutical Companies in Liverpool: 134 Active Firms (2026)
Pharmaceutical companies in Liverpool develop, manufacture and distribute regulated medicines across the surrounding metropolitan area.
Buying decisions tend to sit with quality, regulatory affairs, supply-chain, commercial and clinical operations teams, rather than with a single central procurement function. Liverpool-area suppliers in this category serve NHS-facing routes, wholesalers, contract manufacturing customers, importers and life-sciences service providers, with a bias towards business-to-business relationships rather than consumer healthcare. Engagements are usually long-cycle: licence readiness, batch release, validated storage, distribution authorisation and pharmacovigilance processes matter as much as price. The target buyer profile is mid-market, but the operating model can be lean, with outsourced manufacturing or specialist quality support sitting beside local warehousing, sales or regulatory staff.
Read more
Liverpool has 134 actively trading pharmaceutical companies, making this a compact metropolitan cohort rather than a national manufacturing cluster. The reported employment footprint is 495 staff; among firms with employment disclosure, 31 of 31 report some headcount. Scale is uneven: 10 companies are above £5M turnover, while 54 were incorporated since 2022, so the local market combines a handful of revenue-visible operators with a sizeable intake of newer, smaller firms. For researchers, that points to a list shaped by distribution, outsourced commercial activity and specialist service links as much as by plant-heavy manufacturing.
MHRA oversight shapes the licence stack for this market. Manufacturers, assemblers and importers of human medicines need an MHRA manufacturer’s licence, must work to good manufacturing practice and are subject to site inspection. Wholesale supply to parties other than patients requires a wholesale distribution licence and good distribution practice compliance. Medicines also need a marketing authorisation before sale, while access to public healthcare channels may depend on cost-effectiveness assessment. ABPI remains the main trade body for research-based pharmaceutical businesses, and its framing usefully separates discovery, licensing, manufacturing, distribution and safety monitoring rather than treating the sector as one activity.
Local development appears likely to stay selective. The cohort has a relatively young intake and few scale-up markers, so many firms will tend to prioritise licence maintenance, distribution partnerships and contract-led commercialisation over fixed manufacturing capacity. Regulatory pressure is unlikely to ease, particularly where importing, batch release and pharmacovigilance sit inside the same operating model. Consolidation may come through distributors and specialist service providers adding licences or local capacity, rather than through a wave of broad pharmaceutical manufacturers moving into the area.
134
Active firms
2026
10
Over £5M
Reported turnover
54
New since 2022
Recent incorporations
Key facts
About 7% of the trading cohort reports turnover above £5M (10 of 134 firms) — the rest sits below that revenue band.
40% of the cohort was incorporated since 2022 (54 firms), so a sizeable share is in its first few filing cycles.
UK human medicines are regulated by the MHRA, with licensing, clinical-trial approval, pharmacovigilance and site-inspection roles across the medicines lifecycle.
Organisations that make, assemble or import human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
£9.0 billion of pharmaceutical R&D was performed by the UK business enterprise sector in 2022, equivalent to 0.36% of UK GDP.
UK pharmaceutical exports were valued at £25.6 billion in 2023, with the UK ranked tenth among comparator countries for this metric.
Top Liverpool Pharmaceutical companies
Copea Pharma Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides pharmaceutical services including QP certification, importation, and secondary packaging and labelling of clinical trial and commercial medicines. Operates MHRA‑licensed warehousing for…
Serves pharmaceutical and biotech companies, clinical trial sponsors, and medicine licence holders handling clinical, commercial, and unlicensed medicinal products for UK/EU markets.
Financial Health
StrongStrong · Growing, Hiring · 22% CAGR over 5y
Location
PHARMARON BIOLOGICS (UK) LTD
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsProvides contract research, development and manufacturing services for pharmaceuticals, biologics and advanced therapies. Supports drug discovery, preclinical testing, clinical development and…
Serves pharmaceutical, biotechnology, cell and gene therapy, vaccine and medical device companies seeking outsourced support from discovery through commercialization.
Financial Health
StableStable · 2% CAGR over 1y
Location
Bora Health Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract development and manufacturing (CDMO) services for pharmaceutical companies, including development and production of small‑molecule and biologic drugs. Also markets and distributes…
Serves B2B customers in the pharmaceutical, biotech, specialty pharma, generics, biosimilar and consumer healthcare sectors, including global drug developers and brand owners seeking outsourced…
Financial Health
StrongStrong · Growing, Hiring · 10% CAGR over 2y
Location
TROPHICELL LTD
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
DistressedDistressed · 0% CAGR over 1y
Location
Azfran Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract manufacturing, private‑label production and formulation development for topical pharmaceutical, cosmeceutical and personal care products. Produces OTC treatments and FMCG skincare…
Serves FMCG, personal care, cosmetics and pharmaceutical brands seeking outsourced topical OTC, cosmeceutical and private-label products, with consumers and patients as downstream users.
Financial Health
DistressedDistressed · -15% CAGR over 2y
Location
MEDAXXESS LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed · -93% CAGR over 2y
Location
AYRTON SAUNDERS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
DERMOTANICAL LTD
Trajectory
2y · 2024–NowFinancial Health
Insufficient historyInsufficient history
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsOperates businesses in science‑led markets, including pharmaceuticals and plastics and industrial additives. Supports the development and commercialisation of products through group divisions focused…
Financial Health
StableStable
Location
HEALTH 123 LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsOperates as part of a group developing and supporting businesses in science‑led markets, with divisions focused on pharmaceutical products and plastics and industrial additives manufacturing and…
Financial Health
DistressedDistressed
Location
Provides research, development, manufacturing and marketing of finished-dose pharmaceutical formulations, including over-the-counter medicines, prescription drugs, vitamins and supplements, and…
Serves healthcare and pharmaceutical businesses worldwide, including strategic partners, distributors and market players supplying OTC consumer self-care and prescription medicines.
Location
Pharmapac (U.K.) Limited
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides contract manufacturing services for pharmaceutical and medical device products, including formulation manufacture, bulk filling, packaging and serialisation. Also offers project management…
Serves B2B customers in the pharmaceutical, medical device and healthcare sectors, including companies with medicinal product portfolios and brands seeking outsourced support from development through…
Financial Health
WeakWeak · Profitable · 5% CAGR over 2y
Location
Great Eccleston Medical Supplies Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures and supplies pharmaceutical medicines across multiple therapeutic classes, including penicillin and cephalosporin products. Operates dedicated production facilities and markets branded…
Serves healthcare and pharmaceutical trade customers, including distributors, pharmacies and international business partners, with end use by patients across therapeutic areas.
Financial Health
DistressedDistressed · -4% CAGR over 4y
Location
BACHEM (U.K.) LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures peptides and oligonucleotides for pharmaceutical and biotechnology applications. Provides contract development and manufacturing services, including CMC development, GMP…
Serves pharmaceutical and biotechnology companies worldwide, including R&D, sourcing, quality, regulatory and production teams requiring peptide and oligonucleotide materials from research through…
Financial Health
WeakWeak · -1% CAGR over 2y
Location
OCTAPHARM LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and manufactures plasma-derived and recombinant protein medicines. Products include treatments for bleeding disorders, immunodeficiency and autoimmune diseases, and therapies used in…
Serves healthcare providers and hospital-based clinicians worldwide treating patients with bleeding disorders, immune deficiencies, autoimmune diseases, and critical care needs; operates in the B2B…
Financial Health
DistressedDistressed · -79% CAGR over 3y
Location
United Pharmaceuticals Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical, nutraceutical and cosmeceutical products, including tablets, capsules, syrups, gummies, metered‑dose inhalers and topical aerosols. Conducts product testing, quality…
Serves healthcare professionals and patients/consumers worldwide in the pharmaceutical, nutraceutical and cosmeceutical markets, including buyers of vitamin, supplement and personal care products.
Financial Health
StrongStrong · Growing · 0% CAGR over 4y
Location
RLC TECHNOLOGY LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · 0% CAGR over 3y
Location
BRINTON HEALTHCARE UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 2y
Location
OurVita
Develops and manufactures private‑label food supplements, medical devices, cosmetics, probiotics, and OTC medicines as a contract development and manufacturing organisation. Provides R&D,…
Serves consumer health, wellness and beauty brands needing outsourced development and manufacturing for food supplements, medical devices, cosmetics, probiotics and OTC medicines.
Location
CORE PHARMACEUTICALS LIMITED
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong · Hiring · 27% CAGR over 3y
Location
Stanton Ocean Services Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · -16% CAGR over 4y
Location
PHARMACEUTICAL TECHNOLOGY CENTRE LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
WeakWeak · 0% CAGR over 2y
Location
SRQP SERVICES LTD
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
StableStable · 0% CAGR over 1y
Location
Morpho Skin n Soul Ltd.
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
DistressedDistressed · 0% CAGR over 1y
Location
Exmed Worldwide Limited
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides procurement and sourcing services for businesses, supplying pharmaceutical and healthcare products and other goods. Sources and wholesales items for sectors including pharmaceuticals,…
Serves businesses seeking procurement support across pharmaceutical, automotive, retail, transport, healthcare, IT, hospitality and catering sectors.
Financial Health
StrongStrong · Hiring · 31% CAGR over 2y
Location
Livful Innovation Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops pharmaceutical and health technologies, including experimental cancer treatments and insect‑repellent products. Identifies and licenses biomedical intellectual property, conducts early‑stage…
Serves underserved populations in the Global South through local health systems, public/private health organisations and pharmaceutical partners, with out-licensing to global north pharma companies.
Financial Health
HealthyHealthy · Hiring · 9% CAGR over 4y
Location
iOphtha Limited
Trajectory
5y · 2019–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable
Location
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsConducts drug discovery research focused on developing therapeutics for oncology, fibrotic and metabolic diseases. Uses multidisciplinary approaches to identify and advance candidate compounds…
Financial Health
DistressedDistressed
Location
FOX GROUP TRADING LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
FOX PHARMA LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsOperates a GPhC‑registered pharmacy supplying aesthetic medical products to clinics, including dermal fillers, skin boosters, polynucleotides, toxins, and related consumables. Also sells devices,…
Serves B2B customers in the medical aesthetics sector, including aesthetics clinics and qualified practitioners seeking pharmacy-supplied treatment products, consumables, training and clinic support.
Financial Health
StableStable · -66% CAGR over 3y
Location
Unlock all 134 leads
Showing 31 of 134 — +103 more with verified decision-maker contacts, live data, and CRM sync.
How Liverpool Pharmaceutical companies work and how to sell to them
What they do
Liverpool pharmaceutical companies usually earn revenue through a mix of product margin, licence-linked commercialisation, contract services and regulated distribution. Many are not pure discovery businesses or plant-heavy manufacturers; the sellable unit may be a medicine pack, an import route, batch release support, validated storage, wholesale access or regulatory service capacity. Pricing tends to follow the risk in the work: repeat supply margins for distribution, project fees for licence preparation, retained quality support for ongoing compliance, and negotiated commercial terms where marketing authorisation or specialist manufacturing partners are involved.
Who they sell to
Typical customers are healthcare suppliers, wholesalers, contract manufacturing clients, importers, clinical operations teams and life-sciences service providers. The buying committee often spans quality assurance, regulatory affairs, supply chain, commercial management and finance, with senior sign-off where licence exposure or public healthcare access is involved. Most sales are relationship-led rather than self-serve, and tend to move through technical qualification, due diligence, audit evidence and legal review. Procurement may include direct negotiation, framework access, tendering or partner-led referral, depending on whether the buyer needs supply, compliance capacity or specialist services.
What they buy
Most pharmaceutical firms tend to spend on systems and services that reduce licence, quality and distribution risk. Common categories include quality management software, document control, batch record systems, regulatory information management, pharmacovigilance workflow, inventory control, warehouse management, finance systems and customer relationship management. They also buy audit support, validation services, specialist legal advice, accountancy, insurance, recruitment, training and logistics support, including temperature-controlled storage or transport where medicines handling requires it. Security, cloud administration and business continuity matter where regulated records, supplier files and batch documentation sit across outsourced partners.
Why and how to sell to them
Pharmaceutical buyers tend to evaluate vendors when a licence application, MHRA inspection, new distribution route, product launch, remediation project or supplier change creates operational pressure. Good outbound usually starts with the regulated process affected, not with a generic productivity claim. A pitch that maps to good manufacturing practice, good distribution practice, marketing authorisation support, audit readiness, traceability or pharmacovigilance is easier for these teams to qualify. Signals worth watching include new quality or regulatory hires, warehouse expansion, import activity, contract wins, clinical supply work and changes in commercial leadership.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Liverpool
Related directories
Frequently asked questions
How many pharmaceutical companies are there in Liverpool?
What counts as a pharmaceutical company in this list?
Which are the largest pharmaceutical companies in Liverpool?
What do pharmaceutical companies in Liverpool actually do?
How does Liverpool pharmaceutical compare internationally?
How is this list built and how fresh is the data?
How big are the typical pharmaceutical companies in Liverpool?
Are these mostly new or established pharmaceutical companies?
What SIC codes does this use?
What buying signals should I look for?
Push these 134 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.